Shopping Cart
- Remove All
Your shopping cart is currently empty
Crizotinib, an orally bioavailable agent, belongs to the class of c-met/hepatocyte growth factor receptor (HGFR) tyrosine kinase inhibitors with potential antineoplastic activity.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $1,670 | 1-2 weeks | |
| 50 mg | $2,180 | 1-2 weeks | |
| 100 mg | $2,800 | 1-2 weeks |
| Description | Crizotinib, an orally bioavailable agent, belongs to the class of c-met/hepatocyte growth factor receptor (HGFR) tyrosine kinase inhibitors with potential antineoplastic activity. |
| Synonyms | PF-2341066, PF2341066, PF-02341066, PF02341066, PF 02341066 |
| Molecular Weight | 510.39 |
| Formula | C23H26Cl2FN5O3 |
| Cas No. | 877399-53-6 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.